Your browser doesn't support javascript.
loading
Effectiveness of BNT162b2 booster after CoronaVac primary regimen in pregnant people during omicron period in Brazil.
Florentino, Pilar T V; Alves, Flávia J O; Cerqueira-Silva, Thiago; de Araújo Oliveira, Vinicius; Júnior, Juracy B S; Penna, Gerson O; Boaventura, Viviane; Werneck, Guilherme L; Pearce, Neil; Rodrigues, Laura C; Barreto, Mauricio L; Barral-Netto, Manoel; Paixão, Enny S.
Affiliation
  • Florentino PTV; Centre of Data and Knowledge Integration for Health, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil; Biomedical Science Institute, University of São Paulo, São Paulo, 41745-715 Brazil. Electronic address: pilar.veras@fiocruz.br.
  • Alves FJO; Centre of Data and Knowledge Integration for Health, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil.
  • Cerqueira-Silva T; Gonçalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz), Salvador, Brazil; Faculty of Medicine, Federal University of Bahia School of Medicine, Salvador, Brazil.
  • de Araújo Oliveira V; Centre of Data and Knowledge Integration for Health, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil; Faculty of Medicine, Federal University of Bahia School of Medicine, Salvador, Brazil.
  • Júnior JBS; Public Health Institute, Federal University of Bahia, Salvador, Brazil.
  • Penna GO; Tropical Medicine Centre, University of Brasília, Fiocruz School of Government, Brasília, Brazil.
  • Boaventura V; Gonçalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz), Salvador, Brazil; Faculty of Medicine, Federal University of Bahia School of Medicine, Salvador, Brazil.
  • Werneck GL; Department of Epidemiology, Social Medicine Institute, State University of Rio de Janeiro, Rio de Janeiro, Brazil; Institute of Collective Health Studies, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Pearce N; London School of Hygiene and Tropical Medicine, London, UK.
  • Rodrigues LC; London School of Hygiene and Tropical Medicine, London, UK.
  • Barreto ML; Centre of Data and Knowledge Integration for Health, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil.
  • Barral-Netto M; Centre of Data and Knowledge Integration for Health, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil; Gonçalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz), Salvador, Brazil; Faculty of Medicine, Federal University of Bahia School of Medicine, Salvador, Brazil.
  • Paixão ES; London School of Hygiene and Tropical Medicine, London, UK.
Lancet Infect Dis ; 22(12): 1669-1670, 2022 12.
Article in En | MEDLINE | ID: mdl-36356609
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / BNT162 Vaccine Limits: Female / Humans / Pregnancy Country/Region as subject: America do sul / Brasil Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / BNT162 Vaccine Limits: Female / Humans / Pregnancy Country/Region as subject: America do sul / Brasil Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Document type: Article Country of publication: United States